168 related articles for article (PubMed ID: 20543567)
1. The retinal dehydrogenase/reductase retSDR1/DHRS3 gene is activated by p53 and p63 but not by mutants derived from tumors or EEC/ADULT malformation syndromes.
Kirschner RD; Rother K; Müller GA; Engeland K
Cell Cycle; 2010 Jun; 9(11):2177-88. PubMed ID: 20543567
[TBL] [Abstract][Full Text] [Related]
2. EEC- and ADULT-associated TP63 mutations exhibit functional heterogeneity toward P63 responsive sequences.
Monti P; Russo D; Bocciardi R; Foggetti G; Menichini P; Divizia MT; Lerone M; Graziano C; Wischmeijer A; Viadiu H; Ravazzolo R; Inga A; Fronza G
Hum Mutat; 2013 Jun; 34(6):894-904. PubMed ID: 23463580
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA-seq identifies a reversible mesodermal activation in abnormally specified epithelia of p63 EEC syndrome.
Soares E; Xu Q; Li Q; Qu J; Zheng Y; Raeven HHM; Brandao KO; Petit I; van den Akker WMR; van Heeringen SJ; Aberdam D; Tang F; Zhou H
Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17361-17370. PubMed ID: 31413199
[TBL] [Abstract][Full Text] [Related]
4. APR-246/PRIMA-1(MET) rescues epidermal differentiation in skin keratinocytes derived from EEC syndrome patients with p63 mutations.
Shen J; van den Bogaard EH; Kouwenhoven EN; Bykov VJ; Rinne T; Zhang Q; Tjabringa GS; Gilissen C; van Heeringen SJ; Schalkwijk J; van Bokhoven H; Wiman KG; Zhou H
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2157-62. PubMed ID: 23355676
[TBL] [Abstract][Full Text] [Related]
5. Allele-specific silencing of EEC p63 mutant R304W restores p63 transcriptional activity.
Novelli F; Lena AM; Panatta E; Nasser W; Shalom-Feuerstein R; Candi E; Melino G
Cell Death Dis; 2016 May; 7(5):e2227. PubMed ID: 27195674
[TBL] [Abstract][Full Text] [Related]
6. Special AT-rich binding protein-2 (SATB2) differentially affects disease-causing p63 mutant proteins.
Chung J; Grant RI; Kaplan DR; Irwin MS
J Biol Chem; 2011 Nov; 286(47):40671-80. PubMed ID: 21965674
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site.
Kirschner RD; Sänger K; Müller GA; Engeland K
Nucleic Acids Res; 2008 May; 36(9):2969-80. PubMed ID: 18388131
[TBL] [Abstract][Full Text] [Related]
8. Correction of Mutant p63 in EEC Syndrome Using siRNA Mediated Allele-Specific Silencing Restores Defective Stem Cell Function.
Barbaro V; Nasti AA; Del Vecchio C; Ferrari S; Migliorati A; Raffa P; Lariccia V; Nespeca P; Biasolo M; Willoughby CE; Ponzin D; Palù G; Parolin C; Di Iorio E
Stem Cells; 2016 Jun; 34(6):1588-600. PubMed ID: 26891374
[TBL] [Abstract][Full Text] [Related]
9. The EEC syndrome and SHFM: report of two cases and mutation analysis of p63 gene.
Ergin H; Semerci CN; Karakuş YT; Scheffer H; Ergin S; Koltuksuz U; Meijer R; Satiroğlu-Tufan NL
Turk J Pediatr; 2010; 52(5):529-33. PubMed ID: 21434540
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63.
Testoni B; Mantovani R
Nucleic Acids Res; 2006; 34(3):928-38. PubMed ID: 16473849
[TBL] [Abstract][Full Text] [Related]
11. Sweating ability of patients with p63-associated syndromes.
Ferstl P; Wohlfart S; Schneider H
Eur J Pediatr; 2018 Nov; 177(11):1727-1731. PubMed ID: 30088137
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects.
Lo Iacono N; Mantero S; Chiarelli A; Garcia E; Mills AA; Morasso MI; Costanzo A; Levi G; Guerrini L; Merlo GR
Development; 2008 Apr; 135(7):1377-88. PubMed ID: 18326838
[TBL] [Abstract][Full Text] [Related]
13. Development of an allele-specific real-time PCR assay for discrimination and quantification of p63 R279H mutation in EEC syndrome.
Barbaro V; Confalonieri L; Vallini I; Ferrari S; Ponzin D; Mantero G; Willoughby CE; Parekh M; Di Iorio E
J Mol Diagn; 2012 Jan; 14(1):38-45. PubMed ID: 22056627
[TBL] [Abstract][Full Text] [Related]
14. Personalized Stem Cell Therapy to Correct Corneal Defects Due to a Unique Homozygous-Heterozygous Mosaicism of Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome.
Barbaro V; Nasti AA; Raffa P; Migliorati A; Nespeca P; Ferrari S; Palumbo E; Bertolin M; Breda C; Miceli F; Russo A; Caenazzo L; Ponzin D; Palù G; Parolin C; Di Iorio E
Stem Cells Transl Med; 2016 Aug; 5(8):1098-105. PubMed ID: 27151912
[TBL] [Abstract][Full Text] [Related]
15. Differential altered stability and transcriptional activity of ΔNp63 mutants in distinct ectodermal dysplasias.
Browne G; Cipollone R; Lena AM; Serra V; Zhou H; van Bokhoven H; Dötsch V; Merico D; Mantovani R; Terrinoni A; Knight RA; Candi E; Melino G
J Cell Sci; 2011 Jul; 124(Pt 13):2200-7. PubMed ID: 21652629
[TBL] [Abstract][Full Text] [Related]
16. Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246/PRIMA-1MET.
Shalom-Feuerstein R; Serror L; Aberdam E; Müller FJ; van Bokhoven H; Wiman KG; Zhou H; Aberdam D; Petit I
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2152-6. PubMed ID: 23355677
[TBL] [Abstract][Full Text] [Related]
17. TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor.
Spiesbach K; Tannapfel A; Mössner J; Engeland K
Int J Cancer; 2005 Apr; 114(4):555-62. PubMed ID: 15578720
[TBL] [Abstract][Full Text] [Related]
18. Protein aggregation of the p63 transcription factor underlies severe skin fragility in AEC syndrome.
Russo C; Osterburg C; Sirico A; Antonini D; Ambrosio R; Würz JM; Rinnenthal J; Ferniani M; Kehrloesser S; Schäfer B; Güntert P; Sinha S; Dötsch V; Missero C
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):E906-E915. PubMed ID: 29339502
[TBL] [Abstract][Full Text] [Related]
19. p63-associated disorders.
Rinne T; Brunner HG; van Bokhoven H
Cell Cycle; 2007 Feb; 6(3):262-8. PubMed ID: 17224651
[TBL] [Abstract][Full Text] [Related]
20. Ectrodactyly-ectodermal dysplasia-cleft syndrome (EEC syndrome) with a developmental delay caused by R304W mutation in the tp63 gene.
Gawrych E; Bińczak-Kuleta A; Janiszewska-Olszowska J; Ciechanowicz A
Ann Acad Med Stetin; 2013; 59(1):11-4. PubMed ID: 24734328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
